The Vsx2 CTCF-binding site, located in intron 3, was targeted with sgRNAs (targeting GAGTCTCTAAAAGTAGGAAA and ACCTAATCAAGCAATCAAGT) using CRISPR/Cas9 technology, resulting in a 485 bp deletion (chr12:84636509-84636993 (GRCm39)). (J:333875)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count